These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 18020422)

  • 1. Cysteine-S-trityl a key derivative to prepare N-methyl cysteines.
    Marcucci E; Bayó-Puxan N; Tulla-Puche J; Spengler J; Albericio F
    J Comb Chem; 2008; 10(1):69-78. PubMed ID: 18020422
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preparation of protected peptidyl thioester intermediates for native chemical ligation by Nalpha-9-fluorenylmethoxycarbonyl (Fmoc) chemistry: considerations of side-chain and backbone anchoring strategies, and compatible protection for N-terminal cysteine.
    Gross CM; Lelièvre D; Woodward CK; Barany G
    J Pept Res; 2005 Mar; 65(3):395-410. PubMed ID: 15787970
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The investigation of Fmoc-cysteine derivatives in solid phase peptide synthesis.
    McCurdy SN
    Pept Res; 1989; 2(1):147-52. PubMed ID: 2577698
    [TBL] [Abstract][Full Text] [Related]  

  • 4. On-resin native chemical ligation for cyclic peptide synthesis.
    Tulla-Puche J; Barany G
    J Org Chem; 2004 Jun; 69(12):4101-7. PubMed ID: 15176835
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preparation and use of cysteine orthoesters for solid-supported synthesis of peptides.
    Huang Z; Derksen DJ; Vederas JC
    Org Lett; 2010 May; 12(10):2282-5. PubMed ID: 20405951
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acid-labile Cys-protecting groups for the Fmoc/tBu strategy: filling the gap.
    Góngora-Benítez M; Mendive-Tapia L; Ramos-Tomillero I; Breman AC; Tulla-Puche J; Albericio F
    Org Lett; 2012 Nov; 14(21):5472-5. PubMed ID: 23075170
    [TBL] [Abstract][Full Text] [Related]  

  • 7. L-cysteine, a versatile source of sulfenic acids. Synthesis of enantiopure alliin analogues.
    Aversa MC; Barattucci A; Bonaccorsi P; Giannetto P
    J Org Chem; 2005 Mar; 70(6):1986-92. PubMed ID: 15760176
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selectively N-protected enantiopure 2,5-disubstituted piperazines: avoiding the pitfalls in solid-phase Fukuyama-Mitsunobu cyclizations.
    Ottesen LK; Olsen CA; Witt M; Jaroszewski JW; Franzyk H
    Chemistry; 2009; 15(12):2966-78. PubMed ID: 19191236
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An efficient synthesis of N-methyl amino acids by way of intermediate 5-oxazolidinones.
    Aurelio L; Box JS; Brownlee RT; Hughes AB; Sleebs MM
    J Org Chem; 2003 Apr; 68(7):2652-67. PubMed ID: 12662035
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enantioselective synthesis of alpha-methyl-D-cysteine and lanthionine building blocks via alpha-methyl-D-serine-beta-lactone.
    Smith ND; Goodman M
    Org Lett; 2003 Apr; 5(7):1035-7. PubMed ID: 12659567
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis of N alpha-(1-phenyl-2-mercaptoethyl) amino acids, new building blocks for ligation and cyclization at non-cysteine sites: scope and limitations in peptide synthesis.
    Tchertchian S; Hartley O; Botti P
    J Org Chem; 2004 Dec; 69(26):9208-14. PubMed ID: 15609957
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of dipeptide derivatives of S-substituted cysteines on the time of fibrinolysis.
    Midura-Nowaczek K; Bruzgo I; Roszkowska-Jakimiec W; Worowski K
    Rocz Akad Med Bialymst; 1996; 41(2):412-6. PubMed ID: 9020554
    [TBL] [Abstract][Full Text] [Related]  

  • 13. On-resin conversion of Cys(Acm)-containing peptides to their corresponding Cys(Scm) congeners.
    Mullen DG; Weigel B; Barany G; Distefano MD
    J Pept Sci; 2010 May; 16(5):219-22. PubMed ID: 20401923
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Solid-phase synthesis of sulfamate peptidomimetics.
    Farrera-Sinfreu J; Albericio F; Royo M
    J Comb Chem; 2007; 9(3):501-6. PubMed ID: 17361992
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Solid-phase functionalization of peptides by an alpha-hydrazinoacetyl group.
    Bonnet D; Grandjean C; Rousselot-Pailley P; Joly P; Bourel-Bonnet L; Santraine V; Gras-Masse H; Melnyk O
    J Org Chem; 2003 Sep; 68(18):7033-40. PubMed ID: 12946145
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ninhydrin as a reversible protecting group of amino-terminal cysteine.
    Pool CT; Boyd JG; Tam JP
    J Pept Res; 2004 Mar; 63(3):223-34. PubMed ID: 15049834
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A viable synthesis of N-methyl cysteine.
    Ruggles EL; Flemer S; Hondal RJ
    Biopolymers; 2008; 90(1):61-8. PubMed ID: 18008337
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Solid-phase synthesis of 1,3-azole-based peptides and peptidomimetics.
    Biron E; Chatterjee J; Kessler H
    Org Lett; 2006 May; 8(11):2417-20. PubMed ID: 16706540
    [TBL] [Abstract][Full Text] [Related]  

  • 19. S-Michael additions to chiral dehydroalanines as an entry to glycosylated cysteines and a sulfa-Tn antigen mimic.
    Aydillo C; Compañón I; Avenoza A; Busto JH; Corzana F; Peregrina JM; Zurbano MM
    J Am Chem Soc; 2014 Jan; 136(2):789-800. PubMed ID: 24372047
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mycothiol disulfide reductase: solid phase synthesis and evaluation of alternative substrate analogues.
    Stewart MJ; Jothivasan VK; Rowan AS; Wagg J; Hamilton CJ
    Org Biomol Chem; 2008 Jan; 6(2):385-90. PubMed ID: 18175009
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.